May 3, 2023
By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE
A gold mine for cutting-edge myopia research, the ARVO Meeting, held April 23 – 27, 2023, in New Orleans, La., featured more than 120 posters and papers on various aspects of myopia.
Here are 20 of the most noteworthy myopia-related posters and papers to link to for the results:
- Global trends in myopia management attitudes and strategies in clinical practice – 2022 Update
- Efficacy in Myopia Control—Odds Versus Absolute Effect
- Current hypotheses and unknowns on the mechanisms of myopia development and myopia progression
- Spectacle lenses with highly aspherical lenslets for myopia control: 4-year clinical trial results
- Accommodative behavior in young eyes with prolonged viewing of electronic devices
- Subjective vision differences with soft contact lenses for myopia control in children and teenagers
- Axial length centile change in response to 0.01% atropine or placebo eye drops – the MOSAIC trial
- Comparison of Axial Length Measurements from Three Biometric Instruments in Myopic Children
- Comparison of myopia progression calculators
- Control of Myopia Using Diffusion Optics Spectacle Lenses: Efficacy and Safety Study (CYPRESS) 42-month results
- Cost-Effectiveness Analysis of Atropine for Treating Myopia Progression in Children
- Descriptive statistical comparison of interventions for myopia control
- Efficacy in Myopia Control—Three-year Predictions from the LAMP Study
- Efficacy of Low Dose Atropine and MiSight in Clinical Practice
- Efficacy of NVK002 low-dose atropine for treatment of pediatric myopia progression over 24 months: Comparison of CHAMP vs. other published trials.
- Light Exposure Therapy for Myopia Control: A Systematic Review and Network Meta-Analysis
- Myopia progression and visual performance of Chinese children wearing Defocus Incorporated Multiple Segments Spectacle Lens (DIMS)
- Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops
- The limits of evidence-based myopia control
- Myopia progression before, during and after the COVID-19 pandemic in North American children
To access the 2022 ARVO research highlights, click here.
